All lobbying filings

INFUSION PROVIDERS ALLIANCE

Lobbying for INFUSION PROVIDERS ALLIANCE

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $110,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 2

Medicare/Medicaid

Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. Issues related to virtual supervision of infusion drugs. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act Issues related to the 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F).

Health Issues

Advocating for access to and reimbursement for biosimilars.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.